Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ®Funding will support clinical trials in vulnerable groups, such as children...
CEPI renforce son partenariat avec Valneva en lui octroyant un nouveau financement de $41,3 millions visant à accroître l’accessibilité du premier vaccin au monde contre le chikungunya Valneva...
Participants completed primary vaccination series (3 doses) with VLA15Primary vaccination series to be followed by a booster approximately one year after completion New York, NY and...
Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants Les participants à l’essai ont reçu les trois doses de VLA15 de la...
Declaration of shares and voting rights - Valneva SE - June 30, 2024 VALNEVA Declaration of shares and voting rights June 30, 2024______________________________________________________________...
Valneva reçoit une autorisation de mise sur le marché en Europe pour le premier vaccin au monde contre le chikungunya, IXCHIQ® Saint Herblain (France), le 1 juillet 2024 – Valneva SE (Nasdaq...
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale et la nomination d’un nouvel administrateur à son conseil d’administration Saint-Herblain (France), le 26...
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ® Saint-Herblain (France), June 24, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty...
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Saint-Herblain (France), June 5, 2024 – Valneva SE (Nasdaq: VALN; Euronext...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.048 | -1.4201183432 | 3.38 | 3.54 | 3.276 | 388625 | 3.43984247 | DE |
4 | -0.168 | -4.8 | 3.5 | 3.54 | 3.114 | 400954 | 3.32641055 | DE |
12 | -0.134 | -3.86612810156 | 3.466 | 4.298 | 3.104 | 585936 | 3.6226886 | DE |
26 | -0.666 | -16.6583291646 | 3.998 | 4.298 | 2.95 | 554207 | 3.58527867 | DE |
52 | -3.424 | -50.6808762581 | 6.756 | 7.168 | 2.95 | 439384 | 4.32523154 | DE |
156 | -8.268 | -71.275862069 | 11.6 | 29.7 | 2.95 | 742543 | 12.65934881 | DE |
260 | 0.257 | 8.35772357724 | 3.075 | 29.7 | 1.784 | 637458 | 11.40475585 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.